Absence of genotoxic effects after exposure of mammalian cells to the recombinant human bone morphogenetic protein 2 (BMP-2) prepared from E. coli

Materialwissenschaft und Werkstofftechnik

Volumn 34, Issue 12, 2003, Pages 1101-1105

  Rumpf, H M ^a   Dopp, E ^a   Rettenmeier, A W ^a   Chatzinikolaidou, M ^a   Jennissen, H P ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

BMP 2; Cisplatin; Micronucleus; Mitosis; Mutagenesis; Toxicology; V79 hamster

Indexed keywords

BMP-2; CISPLATIN; GENOTOXIC EFFECTS; MAMMALIAN CELLS; MICRONUCLEUS ASSAY; MITOSIS; TOXICOLOGY; V79 HAMSTER;

AMINO ACIDS; BIOASSAY; BONE; CELLS; ESCHERICHIA COLI; MUTAGENESIS; PATHOLOGY; PROTEINS; PURIFICATION; TOXICITY;

GENETIC ENGINEERING;

EID: 1642569570     PISSN: 09335137     EISSN: None     Source Type: Journal    
DOI: 10.1002/mawe.200300711     Document Type: Conference Paper

References (30)

1. H. Cheng, W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. Breyer, P. Vanichakarn, J. P. Szatkowski, J. Y. Park, T. C. He, J. Bone Joint Surg. Am., 2003, 85-A, 1544.
2. H.P. Jennissen, M. Chatzinikolaidou, H. M. Rumpf, T. Lichtinger, R. Müller, 2000 Modification of Metal Surfaces and Biocoating of Implants with Bone-Morphogenetic Protein 2 (BMP-2). In DVM Bericht pp. 127-140. DVM, Berlin (ISSN 1615-2298).
3. H. P. Jennissen, Annals N. Y. Acad. Sci. 2002, 961, 139.
4. T. K. Lichtinger, R. T. Müller, N. Schürmann, M. Wiemann, M. Chatzinikolaidou, H. M. Rumpf, H. P. Jennissen, Materialwiss. Werkstofftech. 2001, 32, 937.
5. G. Voggenreiter, K. Hartl, M. Chatzinikolaidou, H. M. Rumpf, H. P. Jennissen, Materialwiss. Werkstofftech., 2001, 32, 942.
6. H. P. Jennissen, T. Zumbrink, M. Chatzinikolaidou, J. Steppuhn, Materialwiss. Werkstofftech., 1999, 30, 838.
7. E. A. Wang, V. Rosen, J. S. D'Alessandro, M. Bauduy, P. Cordes, T. Harada, D. I. Israel, R. M. Hewick, K. M. Kerns, P. LaPan, Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U. S. A, 1990, 87, 2220.
8. Y. Maruoka, S. Oida, T. Iimura, K. Takeda, I. Asahina, S. Enomoto, S. Sasaki, Biochem Mol. Biol. Int. 1995, 35, 957.
9. R. Ruppert, E. Hoffmann, W. Sebald, Eur. J. Biochem, 1996, 237, 295.
10. C. M. Dobson, Nature 2003, 418, 729.
11. J. A. Heddle, Mutat. Res. 1973, 18, 187.
12. D. Schiffmann, U. De Boni, Mutat. Res. 1991, 246, 113.
13. W. Schmid, Mutat. Res, 1975, 31, 9.
14. M. Fenech, Mutat. Res, 2000, 455, 81.
15. E. Dopp, J. Saedler, H. Stopper, D. G. Weiss, D. Schiffmann, Environm. Health Perspect. 1995, 103, 268.
16. E. Dopp, M. Schuler, D. Schiffmann, D. Eastmond, Mutat. Res. 1997, 377, 77.
17. M. Kirsch-Volders, T. Sofuni, M. Aardema, S. Albertini, D. Eastmond, M. Fenech, M. Ishidate, E. Lorge, H. Norppa, J. Surralles, von der,H.W., A. Wakata, Environ Mol Mutagen 2000, 35, 167.
18. M. Wiemann, H. M. Rumpf, D. Bingmann, H. P. Jennissen, Materialwiss. Werkstofftech. 2001, 32, 931.
19. H. P. Jennissen, T. Zumbrink, M. Chatzinikolaidou, J. Steppuhn, Materialwiss. Werkstofftech. 1999, 30, 838.
20. J. M. Wozney, V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, E. A. Wang, Science 1988, 242, 1528.
21. J. Portugal, M. J. Waring, Biochim. Biophys. Acta, 1988, 949, 158.
22. M. Lohani, E. Dopp, H. Becker, K. Seth, D. Schiffmann, Q. Rahmann, Toxicol Lett. 2002, 136, 55.
23. P. I. Countryman, J. A. Heddle, Mutat. Res. 1976, 41, 321.
24. S. Meintieres, A. Biola, M. Pallardy, D. Marzin, Environ Mol Mutagen 2003, 41, 14.
25. N. Yajima, Y. Kurata, T. Sawai, Y. Takeshita, Mutagenesis 2003, 8, 221.
26. M. Shin, B. Kim, W. Mar, M. Fang, J. Son, M. Kim, H. Kwak, M. Bae, T. Byun, B. Park, J. Byun, G. An, B. Lee, M. Cho, Arzneimittelforschung 2000, 50, 316.
27. H. Soda, E. Raymond, S. Sharma, R. Lawrence, C. Cerna, L. Gomez, G. A. Timony, D. D. Von Hoff, E. Izbicka, Anticancer Drugs 1998, 9, 327.
28. W. Frieauff, F. Pötter-Locher, A. Cordier, W. Suter, Mutat. Res. 1998, 413, 57.
29. A. H. Reddi, Clin. Orthop. 1995, 313, 115.
30. T. Nakaoka, K. Gonda, T. Ogita, Y. Otawara-Hamamoto, F. Okabe, Y. Kira, K. Harii, K. Miyazono, Y. Takuwa, T. Fujita, J. Clin. Invest, 1997, 100, 2824.